News

Watch: Dolly Parton Gets The Vaccine, While Singing To The Tune Of ‘Jolene’

The Bay's best newsletter for underground events & news

Image: @DollyParton via Twitter

The nation breathes a collective sigh of relief, as living national treasure and drag queen icon Dolly Parton has been administered the COVID-19 vaccine. Dolly herself posted the video below of her getting the vaccine at the Vanderbilt University Medical Center on Tuesday, and as a bonus, she does a Weird Al-style parody of her own song “Jolene” where she instead sings “Vaccine.”

To the tune of her 1973 smash hit “Jolene,” Dolly sings: “Vaccine, vaccine, vaccine, vacciiiiine / I’m beggin’ of you please don’t hesitate / Vaccine, vaccine, vaccine, vacciiiiine / ‘cause once your dead, then that’s a bit too late.”

“I’ve been waiting awhile, I’m old enough to get it and I’m smart enough to get it,” Dolly says of the Moderna vaccine, for which she is perfectly dressed to receive in a cold-shoulders top. 

There is plenty of charming banter in the vaccine video, as Dolly quips to Dr. Naji Abumrad in the 4-minute-long segment, “It didn’t take this long to film 9 to 5.”

As we reported in November, Dolly herself helped fund the Moderna vaccine with $1 million of her own money that she donated to the Vanderbilt University Medical Center. You can see right here in the New England Journal of Medicine that funding for this vaccine came, in part, from “the Dolly Parton COVID-19 Research Fund (Vanderbilt University Medical Center).” 

And in true Dolly fashion, she did not even jump the line to get a shot of the vaccine she paid to help develop. Dolly, we will always love you.

Previous post

‘Beach Blanket Babylon’ Venue Club Fugazi Is Getting A New Show

Next post

Trendy New App Clubhouse Burns All Of Your Contacts’ Privacy


Joe Kukura- Millionaire in Training

Joe Kukura- Millionaire in Training

Joe Kukura is a two-bit marketing writer who excels at the homoerotic double-entendre. He is training to run a full marathon completely drunk and high, and his work has appeared in the New York Times and Wall Street Journal on days when their editors made particularly curious decisions.